Angela Fleischman
Research Rotation Director · UC Irvine School of Medicine
Credentials: · · · · · ·
History
- Present
- Present
UC Irvine School of Medicine
- Present
- 2008–2010
Medical Oncology
- 2005–2008
Internal Medicine
Research
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML
New England Journal of Medicine · 2013 · 454 citations
Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines
Nature · 2000 · 288 citations
TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms
Blood · 2011 · First of 18 authors · Corresponding · 248 citations
9 papers
7 papers
6 papers
5 papers
5 papers
5 papers
- ML
5 papers
5 papers
Grants
- 2025–2030
Medical Scientist Training Program
National Institute of General Medical Sciences · T32
PI · $1.3M · University of California-Irvine
- 2022–2027
National Cancer Institute · R37
Contact PI · $2.9M · University of California-Irvine
- 2022–2025
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $773.9K · University of California-Irvine
Clinical trials
- 2022–2026
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
Principal investigator · Recruiting · Phase 1, Phase 2
University of California, Irvine
- 2021
Remotely Administered Diet Intervention to Impact Symptom Burden in Myeloproliferative Neoplasm
Principal investigator · Completed · Phase 2
University of California, Irvine
- 2018–2019
The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase
Principal investigator · Completed
University of California, Irvine